Corrigendum to: Tumor regression by phenethyl isothiocyanate involves DDB2 (Cancer Biology & Therapy, (2013), 14, 2, (108-116), 10.4161/cbt.22631);Tumor regression by phenethyl isothiocyanate involves DDB2

Cancer Biology and Therapy

Volumn 14, Issue 2, 2013, Pages 108-116

  Roy, Nilotpal ^a   Elangovan, Indira ^a   Kopanja, Dragana ^a   Bagchi, Srilata ^a   Raychaudhuri, Pradip ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apoptosis; Colon cancer; DDB2; Drug resistance; PEITC; ROS; Senescence

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLINE; DAMAGED DNA BINDING PROTEIN 2; DNA BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENETHYL ISOTHIOCYANATE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMOOTH MUSCLE ACTIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL AGING; CELL STRAIN HCT116; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR REGRESSION;

EID: 84873433508     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2017.1313510     Document Type: Erratum

References (39)

1. Sugasawa K, Okuda Y, Saijo M, Nishi R, Matsuda N, Chu G, et al. UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 2005; 121:387-400; PMID:15882621; http://dx.doi.org/10.1016/j. cell.2005.02.035.
2. Stoyanova T, Roy N, Kopanja D, Bagchi S, Raychaudhuri P. DDB2 decides cell fate following DNA damage. Proc Natl Acad Sci USA 2009; 106:10690-5; PMID:19541625; http://dx.doi.org/10.1073/pnas.0812254106.
3. Nag A, Bondar T, Shiv S, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells. Mol Cell Biol 2001; 21:6738-47; PMID:11564859; http://dx.doi.org/10.1128/MCB.21.20. 6738-6747.2001.
4. Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Mol Cell Biol 2008; 28:177-87; PMID:17967871; http://dx.doi.org/10.1128/MCB.00880-07.
5. Kapetanaki MG, Guerrero-Santoro J, Bisi DC, Hsieh CL, Rapić-Otrin V, Levine AS. The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites. Proc Natl Acad Sci USA 2006; 103:2588-93; PMID:16473935; http://dx.doi.org/10.1073/pnas. 0511160103.
6. Luijsterburg MS, Lindh M, Acs K, Vrouwe MG, Pines A, van Attikum H, et al. DDB2 promotes chromatin decondensation at UV-induced DNA damage. J Cell Biol 2012; 197:267-81; PMID:22492724; http://dx.doi.org/10.1083/jcb.201106074.
7. Wang H, Zhai L, Xu J, Joo HY, Jackson S, Erdjument-Bromage H, et al. Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol Cell 2006; 22:383-94; PMID:16678110; http://dx.doi.org/10.1016/j.molcel.2006.03.035.
8. Stoyanova T, Roy N, Bhattacharjee S, Kopanja D, Valli T, Bagchi S, et al. p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies. J Biol Chem 2012; 287:3019-28; PMID:22167187; http://dx.doi.org/10.1074/jbc. M111.295816.
9. Stoyanova T, Roy N, Kopanja D, Raychaudhuri P, Bagchi S. DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response. Cell Cycle 2009; 8:4067-71; PMID:19923893; http://dx.doi.org/10.4161/ cc.8.24.10109.
10. Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P. DDB2, an essential mediator of premature senescence. Mol Cell Biol 2010; 30:2681-92; PMID:20351176; http://dx.doi.org/10.1128/MCB.01480-09.
11. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1:639-49; PMID:12479224.
12. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233.
13. Minig V, Kattan Z, van Beeumen J, Brunner E, Becuwe P. Identification of DDB2 protein as a transcriptional regulator of constitutive SOD2 gene expression in human breast cancer cells. J Biol Chem 2009; 284:14165-76; PMID:19339246; http://dx.doi.org/10.1074/jbc.M808208200.
14. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approachNat Rev Drug Discov 2009; 8:579-91; PMID:19478820; http://dx.doi.org/10.1038/nrd2803.
15. Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L. Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecol Oncol 2006; 103:261-70; PMID:16624391; http://dx.doi.org/10.1016/j.ygyno.2006.03.002.
16. Wang LG, Chiao JW. Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review). [review]. Int J Oncol 2010; 37:533-9; PMID:20664922; http://dx.doi.org/10.3892/ijo-00000702.
17. Xiao D, Singh SV. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signalregulated kinases. Cancer Res 2002; 62:3615-9; PMID:12097262.
18. Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, Singh SV. Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax. Clin Cancer Res 2005; 11:2670-9; PMID:15814648; http://dx.doi.org/10.1158/1078-0432.CCR-04-1545.
19. Hu R, Kim BR, Chen C, Hebbar V, Kong AN. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 2003; 24:1361-7; PMID:12819185; http://dx.doi.org/10.1093/carcin/bgg092.
20. Khor TO, Cheung WK, Prawan A, Reddy BS, Kong AN. Chemoprevention of familial adenomatous polyposis in Apc(Min/+) mice by phenethyl isothiocyanate (PEITC). Mol Carcinog 2008; 47:321-5; PMID:17932952; http://dx.doi.org/10.1002/ mc.20390.
21. Tan T, Chu G. p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol 2002; 22:3247-54; PMID:11971958; http://dx.doi.org/10.1128/MCB.22.10.3247-3254.2002.
22. Benhar M, Engelberg D, Levitzki A. ROS, stressactivated kinases and stress signaling in cancer. EMBO Rep 2002; 3:420-5; PMID:11991946; http://dx.doi.org/10.1093/embo-reports/kvf094.
23. Park HJ, Carr JR, Wang Z, Nogueira V, Hay N, Tyner AL, et al. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J 2009; 28:2908-18; PMID:19696738; http://dx.doi.org/10.1038/emboj.2009.239.
24. Zhou XF, Shen XQ, Shemshedini L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol Endocrinol 1999; 13:276-85; PMID:9973257; http://dx.doi.org/10.1210/me.13.2.276.
25. Benkoussa M, Brand C, Delmotte MH, Formstecher P, Lefebvre P. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 2002; 22:4522-34; PMID:12052862; http://dx.doi.org/10.1128/MCB.22.13. 4522-4534.2002.
26. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006; 10:241-52; PMID:16959615; http://dx.doi.org/10.1016/j.ccr.2006.08.009.
27. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008; 14:458-70; PMID:19061837; http://dx.doi.org/10.1016/j.ccr.2008.11.003.
28. Bagchi S, Raychaudhuri P. Damaged-DNA Binding Protein-2 Drives Apoptosis Following DNA Damage. Cell Div 2010; 5:3; PMID:20205757; http://dx.doi.org/10. 1186/1747-1028-5-3.
29. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/35042675.
30. Soussi T, Lozano G. p53 mutation heterogeneity in cancer. Biochem Biophys Res Commun 2005; 331:834-42; PMID:15865939; http://dx.doi.org/10.1016/j.bbrc. 2005.03.190.
31. Vazquez A, Bond EE, Levine AJ, Bond GL. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008; 7:979-87; PMID:19043449; http://dx.doi.org/10.1038/nrd2656.
32. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109:335-46; PMID:12015983; http://dx.doi.org/10.1016/ S0092-8674(02)00734-1.
33. Vergel M, Marin JJ, Estevez P, Carnero A. Cellular senescence as a target in cancer control. J Aging Res 2010; 2011:725365; PMID:21234095.
34. Itoh T, O'Shea C, Linn S. Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53. Mol Cell Biol 2003; 23:7540-53; PMID:14560002; http://dx.doi.org/10.1128/MCB.23.21.7540-7553.2003.
35. Zhao Q, Barakat BM, Qin S, Ray A, El-Mahdy MA, Wani G, et al. The p38 mitogen-activated protein kinase augments nucleotide excision repair by mediating DDB2 degradation and chromatin relaxation. J Biol Chem 2008; 283:32553-61; PMID:18806262; http://dx.doi.org/10.1074/jbc.M803963200.
36. Zhong SP, Ma WY, Dong Z. ERKs and p38 kinases mediate ultraviolet B-induced phosphorylation of histone H3 at serine 10. J Biol Chem 2000; 275:20980-4; PMID:10806218; http://dx.doi.org/10.1074/jbc. M909934199.
37. Cheung P, Allis CD, Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell 2000; 103:263-71; PMID:11057899; http://dx.doi.org/10.1016/S0092-8674(00)00118-5.
38. Chaveroux C, Jousse C, Cherasse Y, Maurin AC, Parry L, Carraro V, et al. Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals. Mol Cell Biol 2009; 29:6515-26; PMID:19822663; http://dx.doi.org/10.1128/MCB.00489-09.
39. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1:2315-9; PMID:17406473; http://dx.doi.org/10.1038/nprot.2006.339.